Publicaciones (17) Publicaciones de RAFAEL ANDRÉS DEL ORBE BARRETO

2024

  1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

    Blood, Vol. 143, Núm. 18, pp. 1807-1815

  2. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

    British Journal of Haematology, Vol. 204, Núm. 4, pp. 1529-1535

2023

  1. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

    HemaSphere, Vol. 7, Núm. 10, pp. E961

  2. Turning universal O into rare Bombay type blood

    Nature communications, Vol. 14, Núm. 1, pp. 1765

2022

  1. Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital

    Anales de Pediatria, Vol. 97, Núm. 1, pp. 4-11

  2. Manejo clínico de las complicaciones agudas de la anemia falciforme: 11 a ̃nos de experiencia en un hospital terciario

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 97, Núm. 1, pp. 4-11

  3. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

    Cancer, Vol. 128, Núm. 13, pp. 2441-2448

  4. Southeast Asian ovalocytosis

    Medicina Clinica, Vol. 159, Núm. 7, pp. 347-348

2021

  1. Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report

    Clinical Case Reports, Vol. 9, Núm. 3, pp. 1304-1306

  2. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency

    Medicina Clinica, Vol. 157, Núm. 5, pp. 253.e1-253.e8

2020

  1. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

    Leukemia, Vol. 34, Núm. 11, pp. 3007-3018

  2. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination

    Leukemia, Vol. 34, Núm. 2, pp. 589-603

2017

  1. Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing

    Research and Practice in Thrombosis and Haemostasis, Vol. 1, Núm. 1, pp. 69-80

2016

  1. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation

    Immunobiology, Vol. 221, Núm. 1, pp. 40-47

  2. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing

    International Journal of Laboratory Hematology, Vol. 38, Núm. 6, pp. 629-638

  3. Hereditary xerocytosis, a misleading anemia

    Annals of Hematology

  4. Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation

    International Journal of Laboratory Hematology